Financial News

2018 2017 2016 2015 2014 2013

Document Date	Document Link
02/13/2018	BASi Reports First Quarter Results
02/08/2018	Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Document Date	Document Link
12/19/2017	BASi Continues Profitability Improvement To Close out Fiscal 2017
12/15/2017	Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017
08/14/2017	BASi Reports Continued Profitability Improvement in Third Quarter
08/08/2017	Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017
05/15/2017	BASi Reports Q2 2017 Results
02/14/2017	BASi Reports First Quarter Results
02/13/2017	Bioanalytical Systems to Release First Quarter Fiscal 2017 Results on Tuesday, February 14, 2017

Document Date	Document Link
12/22/2016	BASi Reports Fiscal 2016 Full Year and Fourth Quarter Results
08/11/2016	BASi Reports Third Quarter Results
05/12/2016	BASi Reports Second Quarter Results
02/16/2016	BASi Reports First Quarter Results

Document Date	Document Link
12/17/2015	BASi Reports Fiscal 2015 Full Year and Fourth Quarter Results
08/13/2015	BASi Reports Third Quarter Net Income of $0.16 per Share
05/14/2015	BASi Reports Second Quarter Results
02/12/2015	BASi Reports First Quarter Results

Document Date	Document Link
12/22/2014	BASi Reports Fourth Quarter and Full Year 2014 Results
08/14/2014	BASi Reports Third Quarter Results
05/15/2014	BASi Reports Second Quarter Results
02/12/2014	BASi Reports First Quarter Results

Document Date	Document Link
12/24/2013	BASi Reports Profitable 4th Quarter and Fiscal 2013
10/18/2013	BASi Reports Profitable Third Quarter
10/11/2013	BASi Files Amended Form 10-K and 10-Q with the SEC
08/21/2013	BASi Files Form 8K Notice of Non-Compliance with a Continued Listing Rule Non-Reliance on Previously Issued Financial Statements
08/14/2013	BASi Files Form 12b-25, Postpones Third Quarter Earnings Release and Conference Call
08/07/2013	Bioanalytical Systems to Release Third Quarter Results Wednesday, August 14, 2013; Conferece Call & Webcast Set for 11:00 a.m. EDT
05/15/2013	Bioanalytical Systems Reports Second Quarter Results
02/14/2013	BASi Reports First Quarter Net Income of $0.02 Per Share Versus A Prior Year First Quarter Net Loss of $0.21 Per Share

Corporate News

2018 2017 2016 2015 2014 2013 2012

Document Date	Document Link
04/04/2018	BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
03/27/2018	Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian

Document Date	Document Link
12/12/2017	BASi Announces Enhanced Bioequivalence Capabilities
11/13/2017	Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
10/03/2017	Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of In Vivo Products and Services
09/19/2017	BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
09/06/2017	BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
08/28/2017	BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design
08/03/2017	BASi Announces Election of R. Matthew Neff to the Board of Directors
07/31/2017	BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex® Automated Blood Sampling Systems
06/27/2017	BASi Completes Refinancing of Senior Secured Credit Facilities
06/20/2017	BASi Names Dr. Gregory C. Davis to Board of Directors
06/07/2017	BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data
05/01/2017	BASi Announces Appointment of Dr. Peter T. Kissinger as Scientific Advisor
03/08/2017	BASi Names Philip Downing Senior Vice President of Preclinical Services

Document Date	Document Link
12/21/2016	BASi Names Alan Loch Director of Business Development
08/25/2016	BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
07/27/2016	BASi Expands Electrochemical Offerings by Partnering with PalmSens BV
05/11/2016	BASi Announces Appointment of New Chief Financial Officer
04/14/2016	BASi Launches New Website and E-Catalogue
03/29/2016	BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™
02/04/2016	BASi Awards Raturn® Systems for Optogenetic Research

Document Date	Document Link
12/14/2015	BASi Names Wendy Perrow to Board of Directors
07/14/2015	BASi Announces Enhancements to the Company's Laboratory Information Management System (LIMS)
03/17/2015	BASi Names Philip A. Downing Vice President of Preclinical Services
02/12/2015	BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services

Document Date	Document Link
12/02/2014	BASi’s Culex® L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
06/12/2014	BASi Names Jeffrey Potrzebowski CFO and James Bourdage VP Bioanalytical Operations
05/30/2014	BASi Hosts In Vivo Drug Discovery Workshop at UCLA

Document Date	Document Link
10/16/2013	BASi Signs Preferred Provider Agreement with G1 Therapeutics
05/02/2013	BASi Launches Innovative Glucose Monitoring Project with Pinnacle Technology

Document Date	Document Link
12/18/2012	BASi to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 11:00 a.m. EDT